Related Experiment Video
Updated: Aug 15, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Interleukin 1 as a tumor cytostatic mediator released from tumor ascites-treated macrophages
1Institute of Immunology, Philipps University, Marburg, Federal Republic of Germany.
Abstract:
Peritoneal macrophages from DBA/2 mice, elicited by injection of Corynebacterium parvum (C.p.), were in vitro activated to Eb tumor cytostasis by incubation with tumor-induced ascites that was harvested 7 days after intraperitoneal Eb injection. The active cytostasis-mediating compound was found to be interleukin 1 (IL 1). When tumor ascites was fractionated according to molecular weight size, the most active IL 1-inducing fraction was found to comprise molecules of greater than 100,000 daltons. The data show that tumor-bearing hosts are capable of producing compounds that induce a high IL 1 secretion which may enable macrophages to mount an antiproliferative effect against tumor cells.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy

